ARCHIVES

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

November 25, 2011

ASCO Updates Guideline On Use Of Tumor Markers

October 27, 2006

Immune Therapy Possible For Metastatic Breast Cancer

September 24, 2004

Consensus Conference On Receptors Planned

June 22, 1979

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

Cancer Panel Statement On Access To Cancer Care.

October 6, 2000